Related Articles by Review for PMID: 34283431

Year	Number of Results
2020	1
2021	3
2022	5
2023	4
2024	1
2025	2

1

Sherchan R, Cannady, Jr P. Sherchan R, et al. 2023 Jan 30. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2023 Jan 30. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 34283431 Free Books & Documents.

2

SARS-CoV-2-neutralising monoclonal antibodies to prevent COVID-19.

Hirsch C, Park YS, Piechotta V, Chai KL, Estcourt LJ, Monsef I, Salomon S, Wood EM, So-Osman C, McQuilten Z, Spinner CD, Malin JJ, Stegemann M, Skoetz N, Kreuzberger N. Hirsch C, et al. Cochrane Database Syst Rev. 2022 Jun 17;6(6):CD014945. doi: 10.1002/14651858.CD014945.pub2. Cochrane Database Syst Rev. 2022. PMID: 35713300 Free PMC article. Review.

3

A Comprehensive Review on the Efficacy of Several Pharmacologic Agents for the Treatment of COVID-19.

Haddad F, Dokmak G, Karaman R. Haddad F, et al. Life (Basel). 2022 Nov 1;12(11):1758. doi: 10.3390/life12111758. Life (Basel). 2022. PMID: 36362912 Free PMC article. Review.

4

Casirivimab/Imdevimab: First Approval.

Deeks ED. Deeks ED. Drugs. 2021 Nov;81(17):2047-2055. doi: 10.1007/s40265-021-01620-z. Drugs. 2021. PMID: 34716907 Free PMC article. Review.

5

Antispike monoclonal antibodies for prevention and treatment of coronavirus disease-2019 in solid organ transplant recipients.

Yetmar ZA, Bhaimia E, Razonable RR. Yetmar ZA, et al. Curr Opin Organ Transplant. 2022 Aug 1;27(4):269-276. doi: 10.1097/MOT.0000000000000981. Curr Opin Organ Transplant. 2022. PMID: 36354253 Review.

6

Casirivimab and imdevimab (REGEN-COV) for post-exposure prophylaxis of COVID-19.

[No authors listed] [No authors listed] Med Lett Drugs Ther. 2021 Aug 23;63(1631):130-131. Med Lett Drugs Ther. 2021. PMID: 34544100 Review. No abstract available.

7

Advances in the Omicron variant development.

Vitiello A, Ferrara F, Auti AM, Di Domenico M, Boccellino M. Vitiello A, et al. J Intern Med. 2022 Jul;292(1):81-90. doi: 10.1111/joim.13478. Epub 2022 Mar 22. J Intern Med. 2022. PMID: 35289434 Free PMC article. Review.

8

A Systematic Review on the Emergence of Omicron Variant and Recent Advancement in Therapies.

Konyak BM, Sharma M, Kharia S, Pandey RP, Chang CM. Konyak BM, et al. Vaccines (Basel). 2022 Sep 5;10(9):1468. doi: 10.3390/vaccines10091468. Vaccines (Basel). 2022. PMID: 36146546 Free PMC article. Review.

9

Expanded Access Programs, compassionate drug use, and Emergency Use Authorizations during the COVID-19 pandemic.

Rizk JG, Forthal DN, Kalantar-Zadeh K, Mehra MR, Lavie CJ, Rizk Y, Pfeiffer JP, Lewin JC. Rizk JG, et al. Drug Discov Today. 2021 Feb;26(2):593-603. doi: 10.1016/j.drudis.2020.11.025. Epub 2020 Nov 27. Drug Discov Today. 2021. PMID: 33253920 Free PMC article. Review.

10

Comparative Analysis of Post-Authorization Measures for Advanced Medicinal Products Authorized in the European Union and in the United States of America Between 2009 and 2023.

Mandslay D, Almeida D, Marques A, Rocha J, Drafi F, Sepodes B, Torre C. Mandslay D, et al. Clin Pharmacol Ther. 2025 Jan;117(1):73-93. doi: 10.1002/cpt.3410. Epub 2024 Aug 14. Clin Pharmacol Ther. 2025. PMID: 39140780 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13 results

Results by year

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Related Articles by Review for PMID: 34283431

13 results

Results by year